<DOC>
	<DOCNO>NCT00216775</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety low-dose interferon-alfa-2b plus ribavirin compare standard-dose combination patient chronic hepatitis C .</brief_summary>
	<brief_title>Comparative Trial Standard Versus Low-dose Peg-Interferon Plus Ribavirin Treatment Chronic Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Clinical diagnosis Chronic Hepatitis C. Must infect genotype 1b virus Hemoglobin level &lt; 8.5g/dL , Platelet count &lt; 50,000/mm3 , Total polymorphonuclear count &lt; 1000/mm3 Pregnancy , Renal dysfunction ,</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>